Medication Interactions with Robitussin DM and Flonase
Robitussin DM (dextromethorphan and guaifenesin) and Flonase (fluticasone) have minimal direct drug interactions with each other, but each has specific interactions you must monitor.
Key Drug Interactions for Dextromethorphan
High-Risk Interactions (Avoid or Use Extreme Caution)
MAO Inhibitors and SSRIs - Risk of Serotonin Syndrome
- Avoid combining dextromethorphan with MAO inhibitors or SSRIs due to risk of life-threatening serotonin syndrome 1, 2
- If patient is taking these medications, provide poison center-initiated follow-up every 2 hours for 8 hours 2
- Watch for hyperthermia (>104°F), agitation, confusion, and muscle rigidity
CYP2D6 Inhibitors
- Atomoxetine and paroxetine inhibit dextromethorphan metabolism by approximately 50% in human liver microsomes 3
- This increases dextromethorphan levels and toxicity risk
- Other strong CYP2D6 inhibitors (quinidine, fluoxetine, bupropion) will have similar effects
Moderate Interactions
CNS Depressants
- Combining dextromethorphan with other CNS agents (benzodiazepines, opioids, antipsychotics, antidepressants) increases fall risk, particularly in older adults 1
- Avoid concurrent use of three or more CNS agents to reduce fall risk 1
Immunosuppressants (Transplant Patients)
- Dextromethorphan can be used in most transplant recipients 4
- Exercise greater caution in liver transplant patients or those with hepatic impairment due to altered metabolism 4
Key Drug Interactions for Guaifenesin
Minimal Significant Interactions
- Guaifenesin has very few clinically significant drug interactions 5, 6
- Use with caution in kidney or lung transplant recipients and patients with renal impairment 4
- No dose adjustment typically needed for most patients
Key Drug Interactions for Fluticasone (Flonase)
CYP3A4 Inhibitors
- While not extensively detailed in the provided evidence for intranasal fluticasone, systemic corticosteroids interact with strong CYP3A4 inhibitors
- Monitor for increased corticosteroid effects if patient takes ketoconazole, itraconazole, ritonavir, clarithromycin (based on general corticosteroid principles)
- Intranasal route has minimal systemic absorption, making these interactions less clinically significant than oral corticosteroids
Special Population Considerations
Older Adults (≥65 years)
- Dextromethorphan/quinidine combination increases fall risk and drug-drug interactions in older adults 1
- Use with caution in this population, particularly when combined with other CNS agents
Patients on Warfarin
- No direct interactions documented with dextromethorphan, guaifenesin, or intranasal fluticasone
- However, monitor INR if adding multiple new medications
Common Pitfalls to Avoid
- Don't overlook over-the-counter medications - Many patients don't report OTC drugs; specifically ask about cold medications, sleep aids, and supplements
- Check for hidden dextromethorphan - Many combination cough/cold products contain dextromethorphan with other active ingredients (acetaminophen, antihistamines)
- Don't assume intranasal steroids are risk-free - While systemic absorption is low, drug interactions can still occur with potent CYP3A4 inhibitors
- Screen for psychiatric medications - The serotonin syndrome risk with dextromethorphan and antidepressants is serious and potentially life-threatening
Clinical Algorithm
Screen medication list for:
- MAO inhibitors or SSRIs → Avoid dextromethorphan or monitor closely
- Strong CYP2D6 inhibitors → Consider alternative cough suppressant
- ≥3 CNS agents → Avoid adding dextromethorphan in older adults
- Immunosuppressants → Use caution with guaifenesin if renal/lung transplant
If interactions identified:
- MAO inhibitors: Absolutely contraindicated with dextromethorphan
- SSRIs: Use alternative (codeine/guaifenesin in appropriate patients) or monitor intensively
- Multiple CNS agents: Consider non-pharmacologic measures or single-agent therapy
Safe alternatives when needed: